Senior insider sale
SYROS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.5K
6.67K shares
What this filing means
YOUNG RICHARD A plans to sell 6.67K shares of SYROS PHARMACEUTICALS, INC. valued at approximately $1.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/10/2024ACC: 0001969223-24-000897
Director
Since Jun 2019
6.67K
Shares to sell
$1.5K
Approx. market value
6.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Compensation
compensation
6/1/2023
4Kcompensation
compensation
9/16/2022
2.67KTotal acquired6.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/1/2023 | Compensation compensation | 4K | — |
9/16/2022 | compensation compensation | 2.67K | — |
| Total | 6.67K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
6.67K
Market value
$1.5K
12/10/2024
Total
Units
6.67K
Value
$1.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/10/2024 | 6.67K | $1.5K | Nasdaq | Planned |
| Total | 6.67K | $1.5K | ||